The link to the live webcast will also be available on the Investors & News section of the Ascendis Pharma website at A replay of the webcast will be available on this section of the Ascendis Pharma ...
Experts say the U.S. needs an additional 2 million to 20 million homes to fix the shortfall, underscoring the challenge of ...
Discover why Altria is still a buy: 6.8% dividend, discounted valuation, FDA-approved nicotine pouches, and $85.40 bull ...
After the Supreme Court’s ban of race-conscious admissions, Black and Hispanic freshmen enrollment dropped at highly ...
A dominant position, even a monopoly, is not illegal under Trinidad and Tobago’s competition law, according to Dr Taimoon ...
Today Commonwealth Bank becomes the first Australian bank to release a report outlining how it is ideating, developing, ...
Atkore Inc. (NYSE:ATKR) Q1 2026 Earnings Call Transcript February 3, 2026 Atkore Inc. beats earnings expectations. Reported ...
On a dark, murky and damp morning the news that the Government wants the countryside to become more diverse will make most farmers wonder if it’s worth pulling on their boots. At present, the ...
And finally, the fourth number is 31%, which is the amount we grew tangible book value per share plus change in accumulated dividends in 2025. As Kevin highlighted, we have more than doubled this ...
Achieve Life Sciences is a late-stage pharma company awaiting FDA approval for Cytisinicline, a novel smoking cessation ...
Amdocs Limited (NASDAQ:DOX) Q1 2026 Earnings Call Transcript February 3, 2026 Amdocs Limited beats earnings expectations. Reported EPS is $1.81, expectations were $1.75. Operator: Thank you for ...
Freeport-McMoRan's Q4 results exceeded low expectations, but underlying production and profitability were weak. Read why FCX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results